Stem cell pioneer sets sights on Japan – Japan Times features Neil Riordan, PhD of Medistem Panama
"We enjoy the advantage of having a large amount of clinical data on 2,000 patients. So we analyzed who received which cells and which cells worked best in different conditions. This allowed us to create our selection process through molecular profiling,” explained Medistem (Panama) Founder and CEO Dr. Neil Riordan. Operating what is arguably [...]